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Abstract Formation and fragmentation of recognition com-
plexes between trioxacarcin A and various DNA sequences
were examined by temperature-dependent UV and CD
spectroscopy, HPLC analysis, and ESI mass spectrometry
with regard to reaction conditions, intermediates, products,
mechanism, and sequence specificity. Cleavage of the
trioxacarcin–DNA complexes provided the natural product
gutingimycin by guanine abstraction. The resulting DNA
with an abasic site was further cleaved into a DNA fragment
withafuranylunitatthe3′-endandanoligonucleotidewitha
phosphorylated 5′-end.
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Introduction
Trioxacarcins are complex natural antitumor antibiotics with
anti-malaria activity [1–3]. The first trioxacarcins were
isolated from streptomycetes in 1981 by Tomita [1, 2]a n d
their structure was elucidated by Shirahata [4]. Gutingimycin
(1) was isolated in 2004 from a marine streptomycete to-
gether with further trioxacarcin derivatives and named ac-
cording to the ancient name of Göttingen [3, 5, 6]. It turned
out to be an interesting natural product because of its mode
of formation. The structure of gutingimycin (1), elucidated
by X-ray analysis, suggested that gutingimycin (1)r e s u l t s
from nucleophilic attack of the N7 atom of a guanine subunit
in DNA at the epoxide of trioxacarin A (2)[ 5]. Natural anti-
biotics like hedamycin and altromycin B are able to inter-
calate into the dsDNA followed by alkylation of guanine at
the N7 position because of their epoxide functionality [7–9].
Like hedamycin, altromycin B or kapurimycin A3 [10, 11],
trioxacarcin A (2) contains an epoxide. Therefore, it has
been proposed that gutingimycin (1) is not built up from
low-molecular-weight precursors [5]. As for other cytotoxic
natural products, it is likely that alkylation of trioxacarin A
(2)i sf o l l o w e db yd e p u r i n a t i o na n dD N As t r a n ds c i s s i o na t
the abasic site [7, 12–14]. Saito obtained derivatives
structurally related to gutingimycin (1) by reaction of
kapurimycin A3 with various oligonucleotides. At 0 °C a
stable ionic intermediate is formed; on heating to 90 °C this
dissociates into a depurinated oligonucleotide and a kapur-
imycin derivative [15, 16]. Hedamycin binds to dsDNA by
intercalation and alkylation with a distinct preference for the
central guanine in the sequence d(CGT) or d(CGG) [8, 17,
18]. The covalent hedamycin-DNA adduct was isolated by
Sheil and characterized by ESI MS [19, 20].
Fromprevious studies it was known, that trioxacarcin A (2)
also forms a stable complex with dsDNA, but did not react
with deoxyguanosine even at higher temperatures [1]. The
aim of this study was to investigate the conditions and mech-
anism of the trioxacarcin-mediated alkylation of dsDNA by
applying high-performance liquid chromatography and high-
resolution electrospray mass spectrometry together with
temperature-dependent UV and CD spectroscopy. In particu-
lar, the influence of the DNA sequence on binding and adduct
formation and the identification of intermediates and cleavage
products like gutingimycin (1) and DNA fragments is
described in detail.
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Methods and materials
The DNA oligomers d(AATTACGTAATT) (4a), d(CAATTA
TAATTG) (4b), d(AATTXGXAATT) (5a–d), and the com-
plementary oligonucleotides d(AATTGGGAATT) (7) and d
(TTAACCCTTAA) (8) were purchased from IBA (Göttingen,
Germany). An oligomer length of eleven or twelve nucleo-
tides was sufficient to provide stability at room temperature
(Tm=22–35 °C). Trioxacarcin A (2) and trioxacarcin B (3)
were obtained by fermentation of Streptomyces sp. isolate
B8652 [6]. The reactions were carried out in aqueous phos-
phate buffer (10 mmol L
−1 Na2HPO4/NaH2PO4,0 . 1m o lL
−1
NaCl, H2O, pH 7.0) with 5 μmol L
−1 dsDNA and trio-
xacarcin A (2) in a 1:2 ratio.
UV spectroscopy
Melting curves were measured on a Perkin–Elmer Lambda
10 UV–visible spectrophotometer in connection with a
Perkin–Elmer PTP-1 Peltier system following the tempera-
ture program: 0 °C (15 min) → 90 °C (180 min) → 0° C
(180 min). dsDNA (30 nmol) was dissolved in 1.5 mL phos-
phate buffer (10 mmol L
−1 Na2HPO4/NaH2PO4, 0.1 mol L
−1
NaCl, H2O, pH 7.0), trioxacarcin A (2) (60 nmol) in 1.5 mL
phosphate buffer was added and the measurement was
performed at a wavelength of λ=260 nm in a quartz cuvette
(1 cm).
CD spectroscopy
CD spectra were obtained on a Jasco J-810 spectropolarim-
eter at room temperature (datamode: CD,bandwidth1.0nm,
slit width: auto, sensitivity: 5 mdeg, time const.: 4.0 s; step
resolution: 0.1 nm, scan speed: 50 nm min
−1, five accumu-
lations). dsDNA (30 nmol) was dissolved in 1.5 mL phos-
phate buffer (10 mmol L
−1 Na2HPO4/NaH2PO4, 0.1 mol L
−1
NaCl, H2O, pH 7.0), trioxacarcin A (2) (60 nmol) in 1.5 mL
phosphate buffer was added and the measurement was
performed in a quartz cuvette (1 cm).
Fig. 1 Gutingimycin (1), triox-
acarcin A (2), and trioxacarcin
B( 3)
Fig. 2 UV-melting curve of
d(AATTACGTAATT) (4a) with
and without trioxacarcin A (2)
(5 μmol L
−1, 1:2)
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A solution of trioxacarcin–DNA (30 nmol) adduct in
phosphate buffer (600μL, 10mmolL
−1 Na2HPO4/NaH2PO4,
0.1 mol L
−1 NaCl, H2O, pH 7.0) was heated to 80 °C for 4 h.
Samples of 60 μL were taken after 0, 15, 30, 45, 60, 75, 90,
120, and 240 min and analyzed by HPLC. The area under
the curve of the trioxacarcin–DNA adduct peak was plotted
versus time to determine the time constant as the slope of the
regression line.
High-performance liquid chromatography
HPLC separations were performed with an Äkta purifier
from Amersham Pharmacia Biotech, a UV900 UV detector
operated at 260 nm, a NewGuard RP-8 Brownlee Precolumn
(15×3.2 mm, 7 μm), and an Aquapore RP-300 Brownlee
Column (220×4.6 mm, 7 μm) from Perkin–Elmer. Samples
were eluted within 45 min with a flow rate of 1 mL min
−1 by
applying a two-stage gradient (5–20% B in 20 min and 20–
45% B in 25 min). Eluent A: 0.1 mol L
−1 triethylammo-
nium acetate buffer (H2O, pH 7.0). Eluent B: 0.1 mol L
−1
triethylammonium acetate buffer (80% acetonitrile and 20%
water, pH 7.0).
Electrospray mass spectrometry
To a solution of 120 nmol dsDNA in phosphate buffer
(10mmolL
−1 Na2HPO4/NaH2PO4, 0.1 mol L
−1 NaCl, H2O,
pH 7.0) a fivefold excess of trioxacarcin A (2) was added.
The resulting mixture was incubated several hours at 0 °C
and the trioxacarcin–DNA adduct formed was isolated by
HPLC. High-resolution mass spectrometry was performed
using an Apex IV 7 T FTICR MS (Bruker Daltonics,
Billerica, MA, USA) equipped with an Apollo electrospray
ion source which was used in the negative ion mode
(capillary voltage 4.2 kV, end plate voltage 3.8 kV). Analytes
were dissolved in a water–methanol (50:50) solution and
introduced by a syringe pump at a flow rate of 2 μLm i n
−1.
Nitrogen was used as drying gas at 100 °C. Hexapole
accumulation was set between 0.2 s to 3.0 s and mass spectra
were acquired within the mass range m/z 400 to 2000 with a
resolution of about 100,000 at m/z 600. The capillary exit
voltage was −80 V, −100 V, −140 V, or −170 V. Decon-
volution and mass calculation for the corresponding ions
were done using Xmass 6.1.2 from Bruker.
Results and discussion
In order to investigate the sequence dependency of guanine
abstraction from dsDNA by trioxacarcin A (2), the two self
complementary DNA oligomers d(AATTACGTAATT) (4a)
and d(CAATTATAATTG) (4b) were investigated with the
reactive guanine located in the center or at the end of the
double strand. The position of guanine was varied to de-
Fig. 3 UV-melting curve of
d(CAATTATAATTG) (4b) with
and without trioxacarcin A (2)
(5 μmol L
−1, 1:2)
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Fig. 4 CD-spectraofselfpairingd(AATTACGTAATT)(4a)w i t h( grey)
and without (black) trioxacarcin A (2)( 5μmol L
−1,1 : 2 ) .T h edashed
line indicates the spectrum obtained after interim heating to 90 °C
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Four additional non-self complementary oligonucleotides
with the general sequence d(AATTXGXAATT) (5a–d)
together with the corresponding complementary strands were
examined with respect to sequence specificity. The sequences
were limited to only one guanine in the double strand in order
to limit alkylation to a single site. It was placed in the central
position investigating all possible alterations of the neighbor-
ing nucleobases using adenine and thymine.
A first approximation of the interaction of trioxacarcin A
(2) with double-stranded DNA can be obtained from tem-
perature dependent UV-spectroscopic measurements of
double-strand stabilities, because double-strand recognition,
formation ofa covalent adduct, nucleobase excision, orstrand
scission are expected to affect DNA stability. A mixture of
double-stranded oligonucleotide d(AATTACGTAATT) (4a)
with two equivalents trioxacarcin A (2) gave a stability of
Tm=41 °C which is significantly higher than the double
strand transition of oligomer 4a without addition of the
natural product (Tm=34 °C) (Fig. 2) indicating a DNA
interaction with the trioxacarcin A (2). For this interaction
intercalation and groove binding of the aglycon is more likely
than covalent linkage of 2, because double-strand stability
obtained for d(AATTACGTAATT) (4a)w i t ht r i o x a c a r c i nB
(3) is similarly increased (Tm=42 °C) even though trio-
xacarcin B (3) is not able to alkylate DNA. In the cooling
cycle the UV melting curve of the 4a/2 mixture provided
only a stability of Tm=28 °C. This destabilization is most
likely because of nucleobase excision initiated at higher
temperatures to yield gutingimycin (1) and a DNA double
strand with apurine site which might further lead to DNA
strand scission.
In contrast, for the oligomer with the terminal guanine 4b
the differences in double-strand stability were not significant
comparingtheselfpairing(Tm=31 °C) with the 1:2 mixture of
oligomer 4b and natural product 2 in the heating (Tm=29°C)
or cooling cycle (Tm=29 °C) (Fig. 3). Apparently, for DNA
recognition of trioxacarcin A (2) the double helix topology is
required which is not sufficiently assured at the terminus of the
helix. Therefore, the guanine placed at the terminal position
cannot act as a nucleophile without the help of helix
recognition. This is in agreement with guanosine itself not
being a nucleophile for trioxacarcin A (2)[ 1].
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Fig. 5 HPLC chromatogram of a mixture of oligonucleotide 4a and trioxacarcin A (2): a at room temperature; b after heating to 90 °C; next to
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Fig. 6 HPLC chromatogram of a mixture of the oligonucleotide 4b and trioxacarcin A (2): a at room temperature; b after heating to 90 °C
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also indicated by CD spectroscopy (Fig. 4). The spectra of
4a and the mixture of 4a with 2 measured at room tem-
perature are quite similar, whereas the CD spectrum of the
4a/2 mixture heated to 90 °C differed by a shift and the
intensity of the Cotton effect around 270, 250, and 220 nm.
For a more detailed picture of trioxacarcin A (2) adduct
formation with dsDNA, high-performance liquid chroma-
tography was applied determining the components present
after mixing at room temperature and after heating to 90 °C.
The HPLC chromatogram of the mixture of oligonucleotide
4a with trioxacarcin A (2) before starting the heating cycle
provided three peaks (Fig. 5a). Next to DNA (4a) and trio-
xacarcin A (2), an additional compound was indicated
which was assigned to the stable covalent complex between
the oligonucleotide and the natural product trioxacarcin A
(4a + 2). The compound corresponding to peak (4a + 2) was
isolated and characterized by high-resolution ESI MS as the
DNA–trioxacarcin A adduct. After heating to 90 °C addi-
tional peaks appeared in the oligonucleotide area together
with gutingimycin (1) and trioxacarcin B (3) generated by
epoxide ring opening of trioxacarcin A (2) with water
(Fig. 5b). The assignment of all HPLC peaks was confirmed
by co-injection and mass spectrometry.
Examining the trioxacarcin A (2) interaction with
oligomer d(CAATTATAATTG) (4b) carrying the guanine
at the terminal position, the HPLC chromatogram turned
out to be quite similar to the HPLC chromatogram obtained
after interaction with DNA 4a. Nevertheless, the yield of
the respective DNA–trioxacarcin adduct (4b + 2) was
significantly lower and gutingimycin (1) was only obtained
in traces after heating (Fig. 6). As indicated in Table 1,
adduct formation of trioxacarcin A (2) with oligonucleotide
4a is about five times more efficient than binding to DNA
4b. Sterically, the nucleophilic attack should be easier at the
end of the double helix, but the ease of adduct formation
turned out to be higher in the central position of the double
strand. Therefore,trioxacarcin A (2) seems to take advantage
of dsDNA recognition by intercalation or groove binding
prior to nucleophilic attack. This recognition behavior is also
described for the natural products hedamycin and altromycin
B of the pluramycin family [7, 8, 21, 22].
The isolated adduct of oligonucleotide 4a with trioxacarcin
A( 2) is stable at room temperature for more than 24 h and at
56 °C for at least 4 h. At 80 °C within 4 h, decay to gutin-
gimycin (1) was observed obeying first-order kinetics (Fig. 7).
In order to get preliminary information about sequence
selectivityintrioxacarcinA(2) recognition and alkylation, all
adenine and thymine combinations were investigated as the
neighboring nucleobases of a central guanine. The four
oligonucleotides 5a–d reacted with trioxacarcin A (2)t o
yield the corresponding adducts, which were characterized
by high-resolution ESI MS. The corresponding HPLC
profiles of oligomers 5a–d with trioxacarcin A (2)b e f o r e
and after heating to 90 °C were almost similar, except for the
peak height of the generated adducts. The conversion rate
was calculated from the peak area proportion of trioxacarcin
A( 2) to the adduct. As indicated in Table 1, the conversion
rate from trioxacarcin A (2) to the corresponding DNA
adducts varied from 1 to 16%. Based on non-self comple-
mentary double strands 5a–d and results obtained by HPLC
and ESI MS, adduct formation seems to be preferred when
thymine is placed next to guanine with thymine neighboring
the 3′-site having a greater impact. It still needs to be inves-
tigatedifthisresultholdsonlyforthymineincomparisonwith
Table 1 Examined oligomers and adduct formation
DNA oligomers Adduct formula [Madduct − 6H]
6− a calcd. /
found mass
[Madduct +N a− 7H]
6− a calcd. /
found mass
Adduct (%)
b
AATTACGTAATT 4a C161H202N43O90P11 752.32 / 752.33 755.99 / 755.99 53
CAATTATAATTG 4b C161H202N43O90P11 752.32 / 752.39 755.99 / 756.00 10
AATTAGTAATT 5a C152H190N40O84P10 704.15 / 704.16 707.81 / 707.83 13
AATTTGAAATT 5b C152H190N40O84P10 704.15 / 704.16 707.81 / 707.82 5
AATTTGTAATT 5c C152H191N37O86P10 702.65 / 702.65 706.31 / 706.31 16
AATTAGAAATT 5d C152H189N43O82P10 705.65 / 705.66 709.31 / 709.32 1
a Adduct ions up to the sevenfold charged ion were observed; the relative intensities varied from oligomer to oligomer
b Conversion rate given by the trioxacarcin A to adduct proportion
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Fig. 7 Kinetic analysis based on a decay of the d(AATTACG
TAATT)–trioxacarcin A adduct (4a + 2)[ 23]
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overpurinesneighboringthetrioxacarcin-substitutedguanine.
Thealkylationofoligomerswithmorethanoneguaninewas
investigated with the double strand formed by the complemen-
tarystrandsd(AATTGGGAATT)(6) and d(TTAACCCTTAA)
(7) which provide a quite stable double strand (Tm=35°C).In
a mixture of 6 + 7 with six equivalents of trioxacarcin A (2)
the double strand stability decreased to Tm=29 °C (heating
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Fig. 8 HPLC chromatograms of a mixture of the DNA double strand d(AATTGGGAATT) (6) + d(TTAACCCTTAA) (7) and trioxacarcin A (2):
a 24 h at 0 °C and b 72 h at 0 °C
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Fig. 9 a ESI mass spectrum of trioxacarin-DNA d(AATTAG
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1144 Anal Bioanal Chem (2008) 390:1139–1147cycle) whereas double strand formation was no longer
detected after heating to 90 °C. This leads to the conclusion
that trioxacarcin A (2) addition and DNA degradation is
accelerated with three neighboring guanines. The high
tendency for adduct formation of trioxacarcin A (2) to dsDNA
6+7a t0° Cw a si n d i c a t e db ya nH P L Cs i g n a la t2 6 . 0m i n
nearly the size of the remaining oligomer 7 (Fig. 8a). Even
after 24 h signals appeared at 30.8 and 31.6 min that were
assigned to DNA 6 functionalized with two equivalents of
trioxacarcin A (2). The amount of double substitution
increased significantly within 72 h reaction time (Fig. 8b).
Further insight into the trioxacarcin A (2)-initiated substi-
tution reaction and the DNA cleavage products were
obtained by additional ESI MS experiments stepwise in-
creasing the capillary-skimmer dissociation energy in the ion
source [24–30]. Like increasing the temperature this also
initiated fragmentation of alkylated DNA followed by strand
cleavage. The adduct of trioxacarcin A (2)w i t ho l i g o m e r5d
was unequivocally assigned by ESI MS with a low capillary
exit voltage of −80 V providing exclusively ions of the
DNA–trioxacarcin complex 5d + 2 (Fig. 9a): ([M − 3H]
3−,
[M − 4H]
4−,[ M− 5H]
5−,a n d[ M− 6H]
6−). By applying
capillary–skimmer dissociation by raising the capillary exit
voltage to −140 V the signals for the DNA–trioxacarcin A
adduct were also found (Fig. 9c). Nevertheless, the adduct
ions were less intense. One of the peaks with the highest
intensity appears at m/z 1026.37; this is assigned tothesingle
negatively charged ion of gutingimycin (1) comparable to the
thermal cleavage product observed already by HPLC.
Depurination is known to result in oligonucleotide strand
scission [19, 20, 27]. Furthermore, it has been reported that
collision-activated dissociation of negatively charged oligo-
nucleotide ions starts with cleavage of a base followed by
cleavage of the 3′ C–O bond of the sugar unit from which
the base was lost [31]. In accordance, two ESI MS peaks
were correlated to the doubly charged w5-fragment ion at m/
z 781.64 (calculated 781.63) and the doubly charged (a6-B)-
type fragment ion at m/z 821.66 (calculated 821.64) of the
oligonucleotide 5d. The accompanying smaller peaks to
the right of w5
2− and [a6-G
T]
2− were assigned to the
corresponding [M + Na − 3H]
2− ions. These fragments
might mechanistically be explained by the initiation of
Scheme 1 Proposed cleavage
reaction of DNA–trioxacarcin
A adduct
Anal Bioanal Chem (2008) 390:1139–1147 1145strand cleavage at C3′ leading to a furanyl unit at the 3′-end
of d(AATTA) and a phosphoryl group at the 5′-end of the
second fragment d(AAATT) [31]. An additional small peak
m/z 801.90 [10 − 4H]
4− can be assigned to the depurinated
oligonucleotide 10 (Scheme 1, together with its sodium peak
m/z 807.40 [10 +N a− 5H]
4−). Nevertheless, oligonucleo-
tide 10 with a double bond between C1′ and C2′ (Scheme 1)
has a calculated mass [10 − 4H]
4− of m/z 801.89 and [10 +
Na − 5H]
4− of m/z 807.38 corresponding to the mass of the
intermediate fragment. This assignment is clearly supported
by the corresponding deconvoluted mass spectra (Figs. 9b
and d).
The fragments observed for depurination and DNA
strand scission of trioxacarcin–DNA adducts are in agree-
ment with the results from Sheil reporting similar oligonu-
cleotide fragmentation in ESI MS–MS experiments for
various hedamycin–DNA adducts [19]. Based on the ESI
MS fragments detected by cleavage of the trioxacarcin–
DNA adduct (5d + 2) the following products and inter-
mediates for the fragmentation of the trioxacarcin–DNA
adduct are proposed (Scheme 1): Depurination is generating
gutingimycin (1) and the oligonucleotide with an abasic site
10 dissociating in fragment 8 with a furanyl unit at the 3′-
end (w5-type fragment) and fragment 9 with a phosphory-
lated 5′-end (a6-B-type fragment). The phosphoester 9 seems
to be a perfect leaving group for generation of a furan.
Theresultsdescribed forthetrioxacarcin–DNA5d adduct
were supported by the mass spectra of the trioxacarcin
adducts with oligonucleotides 4a–b and 5a–c. The signals
assigned to adducts, abasic sites, fragments, and gutingi-
mycin were also observed for these oligomer adducts. With
low dissociation energy in the ion source (capillary exit
potential −80 V) the adduct peak was obtained for the self
complementary double strand 4a with guanine in the central
position almost exclusively, whereas fragmentation already
occurred in the case of oligomer 4b with the terminal
guanine obtaining the gutingimycin signal as the most
prominent. Trioxacarcin A adducts with oligonucleotides
5a–c always provided the strongest ESI MS signals for the
adduct peaks using the lowest dissociation energy; never-
theless, the peak intensities corresponding to the other
fragments varied. The trioxacarcin adducts with oligomers
5a and 5d were the most stable.
Conclusions
The formation of stable adducts of the natural product
trioxacarcin A (2) with guanine-containing dsDNA was
investigated by a combination of temperature-dependent UV
and CD spectroscopy, high-performance liquid chromatog-
raphy, and high-resolution mass spectrometry. Recognition
and non-covalent binding of trioxacarcin A (2) to dsDNA
seems to be a prerequisite for nucleophilic attack of the
guanine to form a covalent complex. Preliminary evidence
indicates that trioxacarcin A-DNA interaction has se-
quence specificity with greater reactivity observed for
guanines 5′ to thymidines. Cleavage of the trioxacarcin–
DNA adducts can be initiated at higher temperatures or by
applying capillary-skimmer dissociation by raising the
capillary exit potential in mass spectrometry experiments
leading to the formation of the bioactive secondary
metabolite gutingimycin and DNA strand scission. As
DNA cleavage products, a fragment with a furanyl unit at
the 3′-end was identified next to an oligonucleotide with a
phosphorylated 5′-end.
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